Date published: 2026-5-8

1-800-457-3801

SCBT Portrait Logo
Seach Input

WDR82 Inhibitors

WDR82 inhibitors constitute a distinctive class of chemical compounds that target the protein WDR82, a significant constituent of multiple protein complexes intricately involved in epigenetic modulation. These inhibitors are meticulously crafted to engage with precise binding pockets or the catalytic site within the structure of the WDR82 protein. By doing so, they induce a controlled alteration in its functional behavior and enzymatic activity, setting off a sequence of events that can reverberate across various biological pathways. WDR82, also acknowledged as WD Repeat Domain 82, stands out for its integral role in orchestrating chromatin remodeling, transcriptional regulation, and proper progression through the cell cycle. Functioning as part of protein assemblies like the SET1/COMPASS complex, WDR82 actively facilitates histone methylation, which ultimately influences gene expression patterns. Consequently, these inhibitors act as regulatory switches, interfering with the normative enzymatic functions of WDR82 and influencing its interactions with other critical biomolecules.

The unique pharmacological action of WDR82 inhibitors stems from their capacity to perturb the equilibrium of molecular interactions that drive cellular processes. By impeding the enzymatic activities or critical interactions of WDR82, these compounds hold the ability to disrupt the finely tuned epigenetic landscape. This disruption can have cascading effects on transcriptional activity, cellular differentiation, and cell cycle progression. The intricate interplay between WDR82 and other epigenetic effectors underscores the significance of exploring these inhibitors to gain deeper insights into the mechanics of epigenetic control and its ramifications in various biological phenomena. In conclusion, the class of WDR82 inhibitors embodies a tailored approach to modulate the activity of WDR82, a linchpin in the intricate web of epigenetic regulation. By strategically interfering with its molecular functions, these inhibitors pave the way for a nuanced exploration of cellular processes that hinge upon epigenetic modifications, with broader implications for our understanding of fundamental biological mechanisms.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

SJ 172550

431979-47-4sc-357403
sc-357403A
10 mg
50 mg
$175.00
$737.00
1
(1)

An inhibitor that targets the WDR82-MLL interaction, which is important for epigenetic regulation. It has shown potential in inhibiting the growth of certain cancer cells.

(5-Bromopyridin-3-yl)(4-(pyrrolidin-1-yl)piperidin-1-yl)methanone

1314241-44-5sc-504278
10 mg
$330.00
(0)

This inhibitor targets the WD40 domain of WDR82 and has shown potential in blocking the WDR82-MLL interaction, leading to altered gene expression patterns.